Management of hepatitis C
Composition of peripheral blood lymphocyte populations during different stages of chronic infection with hepatitis B virus
Identification of novel sequences at the 5′ terminus of the hepatitis C virus genome
In subjects with antibody to hepatitis C virus a high serum level of interleukin-2 soluble receptor suggests activity of liver disease
Statistical models for predicting a beneficial response to interferon-α in patients with chronic hepatitis B
Prospective virological follow-up of hepatitis C infection in a haemodialysis unit
Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus
Medical practices regarding hepatitis C virus infection in Europe